Search results for "Type A"

showing 10 items of 111 documents

Is BRCA1-5083del19, identified in breast cancer patients of Sicilian origin, a Calabrian founder mutation?

2007

Various studies have been published in Italy regarding the different BRCA1 mutations, but only the BRCA1-5083del19 mutation is recurrent and specific to individuals of Italian descent with a founder effect on the Calabrian population. In our previous study, BRCA1-5083del19 mutation carriers were found in four index cases of 106 Sicilian patients selected for familial and/or hereditary breast/ovarian cancers. The high frequency rate of this mutation identified in the Sicilian population led us to perform haplotype analysis in all family carriers. Five highly polymorphic microsatellite markers were used (D17S1320, D17S932, D17S1323, D17S1326, D17S1325) to establish whether or not all these fa…

MaleCancer ResearchSettore MED/06 - Oncologia MedicaPopulationBRCA1 breast cancerBreast NeoplasmsBiologyRisk AssessmentAllelotype AnalysisReference ValuesHumansAlleleeducationSicilySequence DeletionOvarian NeoplasmsGeneticseducation.field_of_studyBRCA1 ProteinHaplotypeFounder Effectlanguage.human_languagePedigreeOncologyMutationMutation (genetic algorithm)languageMicrosatelliteFemaleSicilianMicrosatellite RepeatsFounder effect
researchProduct

A Type A and Type D Combined Personality Typology in Essential Hypertension and Acute Coronary Syndrome Patients: Associations with Demographic, Psyc…

2016

Many studies have focused on Type A and Type D personality types in the context of cardiovascular diseases (CVDs), but nothing is known about how these personality types combine to create new profiles. The present study aimed to develop a typology of Type A and Type D personality in two groups of patients affected by and at risk for coronary disease. The study involved 711 patients: 51.6% with acute coronary syndrome, 48.4% with essential hypertension (mean age = 56.4 years; SD = 9.7 years; 70.7% men). Cluster analysis was applied. External variables, such as socio-demographic, psychological, lifestyle, and clinical parameters, were assessed. Six groups, each with its own unique combined pe…

MaleEmotionsSocial Scienceslcsh:Medicine030204 cardiovascular system & hematologyAnxietyCardiovascular MedicineEssential hypertensionInhibitionsType D Personality0302 clinical medicinecardiovascular diseaseRisk FactorsMedicine and Health SciencesPsychologyPublic and Occupational Health030212 general & internal medicineBig Five personality traitslcsh:ScienceDepression (differential diagnoses)media_commonMultidisciplinaryAlcohol ConsumptionPersonality types Type A Type DDepressionPersonality typeMiddle AgedAcute Coronary Syndrome; Aged; Anxiety; Depression; Female; Humans; Intracranial Hypotension; Male; Middle Aged; Risk Factors; Sedentary Behavior; Self Concept; Social Adjustment; Social Behavior; Stress Psychological; Life Style; Type A Personality; Type D Personality; Biochemistry Genetics and Molecular Biology (all); Agricultural and Biological Sciences (all)Cardiovascular DiseasesAnxietyFemalemedicine.symptomSocial AdjustmentResearch ArticlePersonalitySettore M-PSI/01 - Psicologia Generalemedicine.medical_specialtyhypertensionmedia_common.quotation_subjectIntracranial HypotensionContext (language use)03 medical and health sciencesMental Health and PsychiatrymedicinePersonalityHumansAcute Coronary SyndromePsychiatrySocial BehaviorLife StyleAgedNutritionPersonality TraitsBehaviorbusiness.industryMood DisordersType D personalitylcsh:RBiology and Life SciencesType A and Type B personality theoryType A PersonalityPhysical Activitymedicine.diseaseSelf ConceptDietcoronary syndromelcsh:QSedentary BehaviorbusinessStress PsychologicalPLoS ONE
researchProduct

Potential influence of Type A personality on plasma C-reactive protein levels in people with diabetes

2016

IF 4.693; Aim. Type A personality, although classically known as a factor linked to increased vascular risk, has recently been associated with increased survival in patients with diabetes. As low-grade inflammation predicts a poor outcome, the present study explored the potential associations between Type A and plasma levels of C-reactive protein (CRP) in diabetes. Methods. Type A personality was assessed by the Bortner questionnaire in people with diabetes. The association between Type A and plasma CRP levels was examined by multivariable linear regression, and structural equation modelling (SEM) was performed to determine the impact of the major clinical, biological and psychological conf…

MaleEndocrinology Diabetes and Metabolism[ SDV.AEN ] Life Sciences [q-bio]/Food and NutritionType 2 diabetesBody Mass Index0302 clinical medicineEndocrinologyc-reactive proteinWeight lossself-care030212 general & internal medicineProspective cohort studymedia_common2. Zero hungerbiologydiabetesGeneral Medicine[SDV.MHEP.EM]Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolismMiddle Aged[ SDV.MHEP.EM ] Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolismanxiety3. Good healthFemalemedicine.symptomweight-lossAdultmedicine.medical_specialtymedia_common.quotation_subjectprospective cohort030209 endocrinology & metabolism03 medical and health sciencesInternal medicineDiabetes mellitus[ SDV.MHEP ] Life Sciences [q-bio]/Human health and pathologyInternal MedicinemedicineHumansPersonalityAgedGlycated Hemoglobintype abusiness.industrybehaviorC-reactive proteinassociationType A PersonalityType A and Type B personality theorymedicine.disease5-factor modelmortalityEndocrinologyDiabetes Mellitus Type 2personalityinflammationbiology.proteinbusinesscoronary-heart-disease[SDV.AEN]Life Sciences [q-bio]/Food and NutritionBody mass index[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct

Long-term efficacy of botulinum toxin A for treatment of blepharospasm,hemifacial spasm, and spastic entropion: a multicentre study using two drug-do…

2009

PURPOSE: To investigate the long-term effectiveness and safety of botulinum neurotoxin A (BoNT-A) treatment in patients with blepharospasm (BEB), hemifacial spasm (HFS), and entropion (EN) and to use for the first time two modified indexes, 'botulin toxin escalation index-U' (BEI-U) and 'botulin toxin escalation index percentage' (BEI-%), in the dose-escalation evaluation. METHODS: All patients in this multicentre study were followed for at least 10 years and main outcomes were clinical efficacy, duration of relief, BEI-U and BEI-%, and frequency of adverse events. RESULTS: BEB, HFS, and EN patients received a mean BoNT-A dose with a significant inter-group difference (P<0.0005, respectivel…

MaleEye diseaseEcchymosisBlepharospasmBlepharospasmBlepharospasm Hemifacial spasmPtosismedicineHumansHemifacial SpasmLongitudinal StudiesBotulinum Toxins Type AAdverse effectAgedDiplopiaAged 80 and overDose-Response Relationship Drugbusiness.industrySettore MED/30 - Malattie Apparato VisivoEntropionMiddle Agedmedicine.diseasebotulinum toxin A; Blepharospasm Hemifacial spasm; entropion; drug-dose escalation indexdrug-dose escalation indexEntropionOphthalmologyDrug CombinationsNeuromuscular AgentsMuscle SpasticityAnesthesiaFemalemedicine.symptombotulinum toxin AbusinessHemifacial spasmFollow-Up Studies
researchProduct

A bioinformatics analysis of Lamin-A regulatory network: a perspective on epigenetic involvement in Hutchinson-Gilford progeria syndrome.

2012

Hutchinson-Gilford progeria syndrome (HGPS) is a rare human genetic disease that leads to premature aging. HGPS is caused by mutation in the Lamin-A (LMNA) gene that leads, in affected young individuals, to the accumulation of the progerin protein, usually present only in aging differentiated cells. Bioinformatics analyses of the network of interactions of the LMNA gene and transcripts are presented. The LMNA gene network has been analyzed using the BioGRID database (http://thebiogrid.org/) and related analysis tools such as Osprey (http://biodata.mshri.on.ca/osprey/servlet/Index) and GeneMANIA ( http://genemania.org/). The network of interaction of LMNA transcripts has been further analyze…

MalePremature agingcongenital hereditary and neonatal diseases and abnormalitiesAginghgps ceRNA lmna progerinBiologyModels BiologicalEpigenesis GeneticLMNAAdenosine TriphosphateProgeriaDatabases GeneticmedicineHumansGene Regulatory NetworksEpigeneticsGeneticsProgeriaModels Geneticintegumentary systemCompeting endogenous RNAComputational BiologyProstatic Neoplasmsnutritional and metabolic diseasesLamin Type Amedicine.diseaseProgerinChromatinChromatinGeriatrics and GerontologySoftwareLamin
researchProduct

Long-term results of simplified frozen elephant trunk technique in complicated acute type A aortic dissection: A case-control study.

2016

Aim To describe the long-term experience of a simplified frozen elephant trunk technique (sFETT) used in complicated acute type A aortic dissection (AAAD) treatment. Methods and results Between January 2001 and December 2012, 34 patients (mean age 59.9 ± 11.0 years) with complicated AAAD (DeBakey I) underwent an emergency surgery including sFETT. sFETT consisted in gluing the dissected aortic arch wall layers with gelatine-resorcinol adhesive and video-assisted antegrade open arch aortic stent-graft deployment in the arch or proximal descending aorta. In addition to sFETT, the aortic root was addressed with standard techniques. A 30-day mortality was 14.7% (five patients) due to bleeding (1…

MaleTime FactorsElephant trunksComputed Tomography AngiographyVideo-Assisted SurgeryKaplan-Meier Estimate030204 cardiovascular system & hematologyComplicated acute type A aortic dissectionSettore MED/22 - Chirurgia VascolareAortic aneurysm0302 clinical medicinePostoperative ComplicationsRisk Factorsfrozen elephant trunkComputed tomography angiographyAortic dissectionAged 80 and overmedicine.diagnostic_testMedicine (all)Endovascular ProceduresGeneral MedicineMiddle AgedAortic AneurysmTreatment OutcomeAcute typeAcute DiseaseFemaleStentsCardiology and Cardiovascular MedicineAdultReoperationmedicine.medical_specialtyAortographyProsthesis DesignAortography03 medical and health sciencesBlood Vessel Prosthesis ImplantationBlood vessel prosthesismedicineHumansRadiology Nuclear Medicine and imagingAgedRetrospective StudiesComplicated acute type A aortic dissection; frozen elephant trunk; Surgery; Medicine (all); Radiology Nuclear Medicine and Imaging; Cardiology and Cardiovascular Medicinebusiness.industryLong term resultsmedicine.diseaseSurgeryBlood Vessel ProsthesisAortic Dissection030228 respiratory systemSurgeryTissue AdhesivesEmergenciesbusinessVascular
researchProduct

Penn classification in acute aortic dissection patients

2016

Objective The objective of this study was to evaluate the effectiveness of the Penn classification in predicting in-hospital mortality after surgery in acute type A aortic dissection patients. Methods We evaluated 58 patients (42 men and 16 women; mean age 62.17 ± 10.6 years) who underwent emergency surgery for acute type A aortic dissection between September 2003 and June 2010 in our department. We investigated the correlation between the pre-operative malperfusion and in-hospital outcome after surgery. Results Twenty-eight patients (48%) were Penn class Aa (absence of branch vessel malperfusion or circulatory collapse), 11 (19%) were Penn class Ab (branch vessel malperfusion with ischaemi…

MaleType A dissection Stanford classification DeBakey classification Penn classificationMyocardial IschemiaRisk AssessmentOutcome Assessment (Health Care)Outcome Assessment Health CarePreoperative CareStanford classificationHumansSettore MED/05 - Patologia ClinicaHospital MortalityAgedType A dissection – Stanford classification – DeBakey classification – Penn classificationPenn classificationSettore MED/23 - Chirurgia CardiacaShockGeneral MedicineMiddle AgedPrognosisAneurysmDeBakey classification; Penn classification; Stanford classification; Type A dissection; Aged; Female; Hospital Mortality; Humans; Italy; Male; Middle Aged; Myocardial Ischemia; Outcome Assessment (Health Care); Preoperative Care; Prognosis; Risk Assessment; Shock; Vascular Surgical Procedures; Aneurysm Dissecting; Aortic AneurysmAortic AneurysmSettore MED/23Aortic DissectionItalyDeBakey classificationType A dissectionFemaleCardiology and Cardiovascular MedicineVascular Surgical ProceduresDissecting
researchProduct

OnabotulinumtoxinA: how deep will it go?

2014

First-line treatment of overactive bladder syndrome (OAB) is based on conservative measures and oral medication such asmuscarinic receptor antagonists and, more recently, b3-adrenoceptor agonists.While this provides effective symptom relief for many patients, for others it has insufficient efficacy and/or intolerable side effects. The potent neurotoxin onabotulinumtoxinA (BoNT-A) has shown efficacy in placebo-controlled trials in patients with neurogenic voiding dysfunction or OAB [1], largely including patients exhibiting an insufficient treatment response to muscarinic antagonists. Although the role of a strong placebo component in the beneficial effects of oral treatment is well known, a…

Malebusiness.industryUrinary Bladder OveractiveUrologyIncidence (epidemiology)Urinary systemAcetylcholine Release InhibitorsPlaceboRefractoryQuality of lifeOral administrationAnesthesiaMedicineHumansFemaleBotulinum Toxins Type AAdverse effectLead (electronics)businessEuropean urology
researchProduct

MRI findings and genotype analysis in patients with childhood onset growth hormone deficiency--correlation with severity of hypopituitarism.

2007

Aim: To evaluate the relationship between pituitary size, PIT1 and PROP1 genotype, and the severity of childhood onset growth hormone deficiency (coGHD). Patients: Forty-four patients with coGHD (34 M; 9.7 ± 4.1 years): severe isolated (SI) GHD (n = 14); partial isolated (PI) GHD (n = 13); multiple pituitary hormone deficiencies (MPHD) (n=17). Results: Pituitary abnormalities were found in 7/14 patients with SIGHD (50%), 16/17 patients with MPHD (94.1%), and no patient with PIGHD. Mean pituitary height (PHT SDS) was significantly lower in MPHD than in SIGHD and PIGHD. Pituitary height SDS and pituitary volume (PV) SDS correlated with IGF-I SDS and stimulated GH peaks in the SIGHD and MPHD g…

Malemedicine.medical_specialtyAdolescentGenotypeEndocrinology Diabetes and MetabolismGenotype AnalysisHypopituitarismHypopituitarismGrowth hormone deficiencyCorrelationEndocrinologyInternal medicineAge Determination by SkeletonGenotypemedicineHumansIn patientAge of OnsetChildDwarfism PituitaryRetrospective StudiesHomeodomain Proteinsbusiness.industrymedicine.diseaseMagnetic Resonance ImagingBody HeightEndocrinologyChild PreschoolPituitary GlandPediatrics Perinatology and Child HealthPituitary hormonesDisease ProgressionFemalebusinessTranscription Factor Pit-1Mri findingsJournal of pediatric endocrinologymetabolism : JPEM
researchProduct

Botulinum Toxin Type B Blocks Sudomotor Function Effectively: A 6 Month Follow Up

2003

This study analyzes the suppression of sweat gland activity by botulinum toxin type B. We injected botulinum toxin type B (between 2 and 1000 mouse units subcutaneously) in the lateral side of both lower legs in 15 healthy volunteers. Sweat tests were carried out before botulinum toxin type B injections, and at 3 wk, 3 mo, and 6 mo. We studied focal anhidrosis by iodine–starch staining and by capacitance hygrometry after carbachol iontophoresis, according to the quantitative sudomotor axon reflex test (QSART). Iodine starch staining indicated that a threshold dose of 8 mouse units botulinum toxin type B leads to anhidrotic skin spots (>4 cm2) after 3 wk. Duration of anhidrosis was prolonged…

Malemedicine.medical_specialtyCarbacholBotulinum ToxinsSweatingDermatologyBiochemistrySWEATSweat glandInternal medicinemedicineHumansHyperhidrosisAnhidrosisBotulinum Toxins Type AMolecular BiologyHypohidrosisLegIontophoresisStaining and Labelingbusiness.industryHyperhidrosisautonomic nervous systemStarchCell BiologySweat GlandsSudomotorEndocrinologymedicine.anatomical_structureAxon reflexFemalemedicine.symptombusinessiodine starch stainingbotulinum toxin Bmedicine.drugFollow-Up StudiesIodineJournal of Investigative Dermatology
researchProduct